Intellectual Property Universal and Master Agreements

Body

Universal and Master Agreements

These agreements are available as starting points for negotiations with particular research sponsors for clinical and, in some cases, preclinical or other types of studies. Faculty members are welcomed to use these documents as starting points; however, all contracts must be processed through the appropriate office at each UT institution.

AbbVie Inc. - Sponsor Initiated Master Clinical Study Agreement - Includes StemCentrx as an Affiliate - Effective 10/20/2016 for 5-year term (does not include Pharmacyclics - see Master CTA for Pharmacyclics [OGC#165622])

Abbott Laboratories - Universal Sponsored Clinical Study Agreement Template

Abbott Laboratories - Universal Sponsored Clinical Study Agreement Template - Pharmaceuticals - 5/9/1994

Abbott Laboratories – Amended and Restated Master Clinical Study Agreement – Abbott Initiated – (Effective 3/26/2012 - 3/26/2019)

Abbott Laboratories - Master Clinical Study Agreement - Abbott Initiated - 12/7/2006

Adria - Universal Research Agreement Template

Amgen, Inc. - Master Clinical Study Agreement for Phase I, II and III Studies Only - 12/27/2000 (UTMDACC, UTHSCHOU, UTMB, UTSMCDAL, UTHSCTY, UTHSCSA)

Amgen Master Materials and Funding Agreement - 6/8/2007

Army Research Laboratory (ARL) - Master Cooperative Research and Development Agreement (CRADA) – 5/30/2014

Astellas Pharma US, Inc. - Master Clinical Study Agreement - 4/18/2007

Astellas Pharma Global Development, Inc. – Amended and Restated Master Clinical Study Agreement – April 18, 2014

AstraZeneca Pharmaceuticals LP (AZPLP) - Universal Sponsor Initiated Clinical Trial Agreement Template (Effective February 1, 2006) 

  • Note:  Please see Letter Agreement between University of Texas System and AstraZeneca, dated 2/14/2006.

AstraZeneca LP/AstraZeneca Pharmaceuticals LP - Sponsor Initiated Master Clinical Study Agreement (Effective 3/16/2015 - 3/15/2020)

AstraZeneca Pharmaceuticals LP & Medimmune Master Mutual CDA  (Effective 2/27/2017)

Biogen - Universal Material Transfer Agreement Template - 6/24/1994

BoehringerIngelheim Pharmaceuticals, Inc. - Universal Clinical Research Agreement Template - 7/13/1995

BoehringerIngelheim Pharmaceuticals, Inc. - Sponsor Initiated Master Clinical Trial Agreement - (Effective 1/25/2012 - 1/25/2021)

BoehringerIngelheim Pharmaceuticals, Inc. (BIPI) - Master Confidential Disclosure Agreement (Effective 11/1/2016 for 5-Year Term [OGC#167258])

Bristol-Myers Squibb - Master Clinical Trial Agreement - 6/23/1998 (including Amendments #1, #2 and #3)

  • Amendment #1 effective 5/21/1999
  • Amendment #2 effective 7/2000
  • Amendment #3 effective 5/18/2001

California Biotechnology - Universal Sponsored Research Agreement Template

Eli Lilly - Master Clinical Trial Agreement - 1/10/1995

  • Amendment #1 Effective 7/21/1998
  • Amendment #2 effective 12/14/1999
  • Amendment #3 effective 3/25/2002
  • Amendment #4 effective 12/12/2003
  • Amendment #5 effective 11/18/2004

Forest Research Institute - Amended and Restated Research Agreement - (Effective 1/1/2011 - 12/31/2017)

Fujisawa - Universal Research and Study Agreement Template

Genentech - Universal Clinical Research Agreement Template

Genentech (and Roche Affiliates) - Investigator Initiated Master Clinical Research Agreement - (Effective 5/1/2018 - 4/30/2028)

Genentech (and Roche Affiliates) - Sponsor Initiated Master Clinical Research Agreement - (Effective 1/16/2015 - 1/15/2025)

Genzyme - Master Clinical Study Agreement - (Effective 4/6/2010 - 4/6/2020)

GlaxoSmithKline (GSK) - Master Clinical Study Agreement - 11/10/2003

GlaxoSmithKline (GSK) - Restated and Amended Master Clinical Study Agreement - (Effective 11/24/2014 - 11/24/2021)

Hoffmann-La Roche - Master Clinical Research Agreement - 5/1/1996

Hoffmann-La Roche - Master Clinical Trial Agreement - 3/16/2009

Hoffmann-La Roche - Universal Preclinical Lab Study Grant Agreement Template - Sponsor IND - 8/30/1994

Hoffmann-LaRoche - Universal Preclinical Lab Study Grant Agreement Template - Funded Institutional IND- 2/14/1996

ICI Americas/Zeneca Pharmaceuticals - Universal Clinical Study Agreement Template - See also AstraZeneca Pharmaceuticals Sponsor Initiated Master Clinical Study Agreement (Effective 3/16/2015)

Integrated Therapeutics Group, Inc. - Universal Clinical Trial Research Agreement Template - 8/2004

InterMune, Inc. - Universal Clinical Study Agreement Template - 1/2005

Janssen Pharmaceutica Inc. - Universal Clinical Study Agreement Template - 4/1995

Lilly USA, LLC - Master Clinical Trial Agreement - (Effective 12/5/2017 - 12/5/2022)

Marion Merrell Dow - Universal Non-Governmental Clinical Study Agreement Template - 2/2/1994

Matrix - Universal Clinical Research Agreement Template

Medimmune & AstraZeneca Pharmaceuticals LP Master -  Master Mutual CDA - 2/27/2017

Merck & Co. - Universal Clinical Study Agreement Template - 6/15/1995

NeoPharm, Inc. - Universal Master Clinical Trial Agreement Template for Sponsor Initiated Studies Only - 12/2002

Novartis Pharmaceuticals Corporation - Master Clinical Trial Agreement – Sponsor Initiated - (Effective 9/1/1998 - 8/31/2003)

  • Amendment #1 (extends term: Effective 9/1/2003 through 12/31/2003)

Novartis Pharmaceuticals Corporation - Master Clinical Trial Agreement – Sponsor Initiated - (Effective 1/1/2004 - 12/31/2008)

Novartis Pharmaceuticals Corporation - Master Clinical Trial Agreement – Sponsor Initiated - (Effective 5/1/2009 - 4/30/2014)

Novartis Pharmaceuticals Corporation - Master Clinical Trial Agreement - Investigator Initiated - (Effective 11/12/2014 - 11/12/2019)

Organon Incorporated - Universal Clinical Trial Agreement Template - 6/14/1995

Pfizer - Amended and Restated Master Clinical Study Agreement (Sponsor Initiated) - (Effective 12/1/2015 - 11/30/2022)

Pfizer - Master Investigator Initiated Research Grant Agreement - (Effective 12/1/2015 - 11/30/2022)

Pfizer - Master Program and Gift Agreement - 2/25/2008

Pfizer - Connecticut - Universal Statement of Agreement Template - Clinical Study

Pfizer - New York - Universal Clinical Study Agreement Template - Pfizer Initiated Study from 6/12/2003

Pfizer - New York - Universal Clinical Study Agreement Template from 1/5/1995

Pharmacyclics LLC - Second Master Clinical Study Agreement - (Effective 1/10/2018 - 1/10/2023)

PPD Investigator Services, LLC (PPD) - Master Confidentiality and Non-Disclosure Agreement - (Effective 12/14/2017 - 12/31/2022)

Regeneron Pharmaceuticals, Inc. - Master Confidentiality Agreement - (Effective 7/5/2018 - 7/5/2028)

Schering Plough Research Institute - Universal Investigator Initiated Master Clinical Trial Research Agreement Template - 7/1/2004

Schering-Plough Research Institute - Master Clinical Trial Research Agreement - (Effective 6/15/2009 - 6/14/2019)

Statewide Clinical Trials Network (CTNeT) – Master Clinical Trial Agreement – (Effective 8/1/2012 - 7/31/2022)

Statewide Master Institutional Review Boards (IRB) Reciprocity Agreement - Signed by all UT System Institutions plus Angelo State University, Baylor College of Medicine, Rice University, Texas A&M University, Texas Tech University, Texas Tech University Health Sciences Center, Texas Tech University Health Sciences Center El Paso, The Methodist Hospital System, University of Houston, and University of North Texas Health Science Center - 4/19/2016 (Effective 7/1/2015 - 6/30/2020)

UCB Biosciences - Master Clinical Trial Agreement - (Effective 8/13/2013 - 8/13/2020)

University Hospital Consortium - Universal Clinical Trial Research Agreement Template -  4/21/1993

Upjohn - Universal Non-Governmental Clinical Study Agreement Template -  10/5/1993

U. S. Department of Veterans Affairs -

UT System - Master Material Transfer Agreement (Effective 7/1/2018 - 7/1/2025)

Warner-Lambert Company - Universal Non-Governmental Clinical Trial Agreement Template - 8/1998

Wyeth Pharmaceuticals, Inc. - Universal Master Clinical Study Agreement Template -   7/22/2003

Xoma - Universal Clinical Research Agreement Template

 

Most of the master contracts specific to a particular UT institution are not available online. Contact BethLynn Maxwell in OGC for copies of standard contracts specific to UT institutions.

 

 

 

Disclaimer: The materials on this website do not constitute legal advice. You should consult with an attorney before acting on or conveying any interpretation of these materials.